Home › Calculator › RDGL Dividend Calculator 2026
RDGL Dividend DRIP Calculator 2026
3407.16% YieldHealthcareVivos Inc. · OTC
Price: $0.06 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When RDGL pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your RDGL snowball 📈
$10,000 in RDGL → $144720.20M in 10 years · $388,351,311.20/month
About Vivos Inc. (RDGL) — Dividend Analysis 2026
Vivos Inc. is a medical technology company focused on radiation oncology, specializing in the development of internal radiation therapy devices for managing tumors that cannot be surgically removed. Their offerings include RadioGel, an injectable particle-gel that utilizes yttrium-90 for targeted radiation treatment of cancerous growths in both humans and animals. Additionally, the company provides IsoPet, a specific treatment for solid tumors found in animals. Established in 1994, Vivos Inc. is based in Richland, Washington. It previously operated under the name Advanced Medical Isotope Corporation before rebranding to Vivos Inc. in December 2017.
Compare RDGL with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full RDGL DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open RDGL position with:
🌍 RDGL Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold RDGL.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 3407.16% | 3404.36% | $340,716 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2896.09% | 2893.29% | $289,609 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2725.73% | 2722.93% | $272,573 / yr |
| 🇬🇧 UK ISA | 0% | 3407.16% | 3404.36% | $340,716 / yr |
| 🇬🇧 UK Taxable | 8.75% | 3109.03% | 3106.23% | $310,903 / yr |
| 🇨🇦 TFSA | 0% | 3407.16% | 3404.36% | $340,716 / yr |
| 🇨🇦 CA Taxable | 25% | 2555.37% | 2552.57% | $255,537 / yr |
| 🇦🇺 Super (pension) | 15% | 2896.09% | 2893.29% | $289,609 / yr |
| 🇦🇺 AU Taxable | 30% | 2385.01% | 2382.21% | $238,501 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2508.52% | 2505.72% | $250,852 / yr |
| 🇫🇷 FR Taxable | 30% | 2385.01% | 2382.21% | $238,501 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 RDGL Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 RDGL Dividend Payment Schedule
RDGL pays quarterly — 4 times per year. Next ex-div: TBD.
📊 RDGL vs Healthcare Benchmarks
How RDGL compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RDGL sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ RDGL Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2026-07-22 | 32,000 | $0.05 | $1.6K | ||
| Buy | 2026-07-21 | 60,000 | $0.05 | $3.0K | ||
| Buy | 2026-07-10 | 12,000 | $0.08 | $960.00 | ||
| Buy | 2026-07-09 | 48,000 | $0.08 | $3.8K | ||
| A-Award | 2026-06-30 | 147,159 | — | — | ||
| A-Award | 2026-03-31 | 100,111 | — | — | ||
| Buy | 2026-07-15 | 200,000 | $0.06 | $11.4K | ||
| Buy | 2026-07-10 | 12,000 | $0.08 | $960.00 | ||
| Buy | 2026-07-09 | 48,000 | $0.08 | $3.8K | ||
| Buy | 2026-05-11 | 150,000 | $0.06 | $9.3K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RDGL dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Vivos Inc. (RDGL) is currently trading at $0.06, 72% below its 52-week high. The current dividend yield is 3407.16% based on an annual payout of $2.00 per share.
RDGL (Vivos Inc.) — 3407.16% Dividend Yield Analysis
Vivos Inc. (RDGL) is a healthcare stock currently trading at $0.06 with a dividend yield of 3407.16%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (3407.16%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.